. Example of gene query to the HemaExplorer Web server. (A) Web server interface for single gene lookup with gene query, options for dataset and scale of axis. (B) Output plot from the Web server displaying gene expression for the ERG transcription factor in the normal myeloid system. CMP indicates common myeloid progenitor cell; GMP, granulocyte monocyte progenitors; HSC_BM, hematopoietic stem cells from bone marrow; MEP, megakaryocyte-erythroid progenitor cell; MY_BM, myelocyte from bone marrow; PMN_BM, polymorphonuclear cells from bone marrow; PMN_PB, polymorphonuclear cells from peripheral blood; PM_BM, promyelocyte from bone marrow; and early HPC_BM, hematopoietic progenitor cells from bone marrow. 6394 BLOOD, 28 JUNE 2012 ⅐ VOLUME 119, NUMBER 26
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Evidence for miRNA expression differences of HIV-1-positive, treatment-naive patients and elite suppressors: a re-analysis
Bignami et al recently reported on miRNA profiles of treatmentnaive HIV-1 patients (naive), elite suppressors (éLTNP or ES), and multiply-exposed, uninfected individuals (MEUs). 1 The authors identified only 1 putative miRNA expression difference between naive and ES and did not confirm results of earlier studies of miRNAs in HIV-1 susceptible cells and infected patients. [2] [3] [4] [5] After re-analyzing the data (Gene Expression Omnibus series GSE33514), we suggest that technical and experimental design issues, including comparisons of patients with a single control sample, may have inappropriately affected the authors' conclusions. Our alternative examination tended to corroborate previous findings.
We posit that the original conclusions may derive from analysis issues and batch effects. There were significant differences in the number of miRNAs detected in MEU or control versus naive/ES ( Figure 1A ; P Ͻ .001). Further, when we used the specified U6 normalization and exclusion criteria, 70 miRNAs of Ͻ 150 detected consistently in MEU had significant apparent expression differences (P Ͻ .05 with multiple comparison correction). Each was rarer in MEUs than infected patients. A uniformly 1-way directionality of expression differences is unusual and inconsistent with previous work 2 ; Figure 1B details additional issues. We conclude that technical factors of RNA integrity and processing (no quality control assessments were provided), measurement, and analysis likely affected results.
The titular case for a retroviral exposure signature is tenuous as presented. First, only unprotected sex suggested exposure of MEUs to HIV-1. The authors did not specify whether individuals had HIV-1-positive sex partners or if these partners were taking antiretrovirals. It seems unusual to define a patient class by conjecture. Second, the normalizing RNA, U6 was not "relatively stable" in these samples, but varied 14-fold. The highest threshold cycle (Ct) was in the healthy donor sample ( Figure 1C) , likely skewing results. Third, 5 members of the proposed octapartite exposure signature 1 (Figure 2A ) failed the authors' inclusion criterion (expression in Ͼ 70% of at least 1 patient group); each was undetected in 13-16 of 17 patient samples. The other 3 were considered up-regulated in patients only because they were undetected in the single control PCR well, insufficient to conclude absence or calculate accurate fold changes. Many such "undetected" miRNAs were found in previous studies of healthy CD4 ϩ T cells. 6, 7 Finally, no meaningful conclusions can be drawn from comparisons made with a single control sample, pooled or not. The authors' gp120 experiments, 1 (Figure 3 ) also lack biologic replicates. With an n ϭ 1, assertions of a retroviral exposure signature and a gp120-mediated miRNA profile shift are preliminary.
Contrasting with the authors' conclusions, alternative analyses using quantile normalized data from miRNAs expressed in the majority of samples revealed multiple naive-to-ES differences. Although confidence in these results remains attenuated by the observations above and would be bolstered by verification with technical replicates and/or different measurement platforms, it is
